Eye Treatments News

Regenera Keeps Its Eye On The Prize

Friday September 3, 2004
Eye disease specialist Regenera expects to announce its first commercial licensing agreement within 60 days, as three North American pharmaceutical companies vie for the rights to its macular degeneration treatment.

News Archive

2008

2007

2006

2005

2004

2003

2002

2001

2000

1999

1998

1996

1995

1994

1993

1992